Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iC9.GD2.CAR.IL-15 T Cells in Lung Cancer
NCT05620342Phase 1Suspended
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Jun 2023
- Primary completion
- Nov 2027
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1 trial, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Jun 2023; status: suspended.
Beyond the preview
Go deeper on NCT05620342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05620342.